Market Cap 1.53B
Revenue (ttm) 1.30B
Net Income (ttm) 48.26M
EPS (ttm) N/A
PE Ratio 15.14
Forward PE 13.53
Profit Margin 3.72%
Debt to Equity Ratio 2.38
Volume 155,500
Avg Vol 305,546
Day's Range N/A - N/A
Shares Out 40.53M
Stochastic %K 29%
Beta 0.77
Analysts Sell
Price Target $41.00

Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, su...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 201 329 7300
Address:
Glenpointe Centre East, 3rd Floor Suite 21 300 Frank West Burr Boulevard, Teaneck, United States
ProverbsP
ProverbsP Dec. 27 at 5:41 AM
$PAHC Markets appear to be rewarding companies that show durable execution rather than rapid narrative shifts. Margins must hold as the company navigates cost pressure. Credible progress tends to compress risk premiums. Execution quality becomes the defining catalyst from here.
0 · Reply
ZacksResearch
ZacksResearch Dec. 16 at 1:34 PM
$PAHC surged 93.7% in the past year — is the rally sustainable? 🚀 🐔 Strong growth in Animal Health, with MFA revenues up 81% in Q1 FY26 in nutritional specialties and vaccines 🌍 Expanding vaccine business and global footprint in approximately 90 countries 📈 Zacks Rank #1 and a 23.7% earnings surprise last quarter Discover why PAHC could keep climbing 👉 https://www.zacks.com/stock/news/2804780/is-phibro-animal-health-stock-a-smart-addition-to-your-portfolio-now?cid=sm-stocktwits-2-2804780-body-24958&ADID=SYND_STOCKTWITS_TWEET_2_2804780_BODY_24958
0 · Reply
ZacksResearch
ZacksResearch Dec. 16 at 12:07 PM
$PAHC riding a powerful Animal Health wave — but risks aren’t gone 🚀 Animal Health momentum, vaccine growth, and rising emerging market demand are driving the story, even as macro pressure and competitive risks continue to linger in the background. See the full bull vs. risk breakdown here 👉 https://www.zacks.com/stock/news/2804780/is-phibro-animal-health-stock-a-smart-addition-to-your-portfolio-now?cid=sm-stocktwits-2-2804780-teaser-24922&ADID=SYND_STOCKTWITS_TWEET_2_2804780_TEASER_24922
0 · Reply
ZacksResearch
ZacksResearch Dec. 10 at 2:41 PM
$PAHC up 59.6% so far this year — what's driving the surge? 🚀 🐾 Animal Health biz momentum & vaccine growth 🌍 Expanding in high-growth regions like Brazil & Southeast Asia 📈 Fiscal 2026 EPS expected to jump 32.1% Discover the full growth story here 👉 https://www.zacks.com/stock/news/2802112/phibro-animal-health-stock-climbs-596-ytd-whats-driving-it?cid=sm-stocktwits-2-2802112-body-24201&ADID=SYND_STOCKTWITS_TWEET_2_2802112_BODY_24201
0 · Reply
ZacksResearch
ZacksResearch Dec. 10 at 12:35 PM
$PAHC’s 59% YTD surge — is this momentum just getting started? Animal Health is firing on all cylinders, with booming vaccines and global gains even as competition heats up. That kind of strength is hard to ignore. Full breakdown here 👉 https://www.zacks.com/stock/news/2802112/phibro-animal-health-stock-climbs-596-ytd-whats-driving-it?cid=sm-stocktwits-2-2802112-teaser-24132&ADID=SYND_STOCKTWITS_TWEET_2_2802112_TEASER_24132
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Dec. 2 at 7:54 PM
$OXSQ $PACK $PAGS $PAHC $PAM Undeniable Accuracy Cycle Trading Signal plugged into AI 🔥 lists 🔥 Math don't lie 🔥
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 23 at 3:45 PM
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 17 at 10:59 AM
0 · Reply
JarvisFlow
JarvisFlow Nov. 7 at 8:06 PM
JP Morgan updates rating for Phibro Animal Health ( $PAHC ) to Overweight, target set at 45 → 50.
0 · Reply
ZacksResearch
ZacksResearch Nov. 3 at 5:44 PM
$INFU surges 75.2% in 3 months — what's fueling the rally? 🚀 🔥 Strong Patient Services & Device Solutions performance 📈 Higher treatment volume and increased third-party payer collections in Oncology and Wound Care boost revenues 🔧 Strategic restructuring with GE Healthcare underway Discover why $INFU is outperforming its peers like $PAHC, $PODD, and $LMAT 👉 https://www.zacks.com/stock/news/2783746/can-strength-in-rental-business-drive-infu-stock-before-q3-earnings?cid=sm-stocktwits-2-2783746-body-19156&ADID=SYND_STOCKTWITS_TWEET_2_2783746_BODY_19156
0 · Reply
Latest News on PAHC
Phibro Animal Health Corporation Declares Quarterly Dividend

Nov 4, 2025, 4:10 PM EST - 7 weeks ago

Phibro Animal Health Corporation Declares Quarterly Dividend


Phibro Animal Health: Zoetis Growth, Valuation Still Attractive

Sep 2, 2025, 9:15 AM EDT - 4 months ago

Phibro Animal Health: Zoetis Growth, Valuation Still Attractive


Overlooked Stock: PAHC Taps 4-Year High

Jul 7, 2025, 5:00 PM EDT - 6 months ago

Overlooked Stock: PAHC Taps 4-Year High


Phibro Animal Health: The Animal Is Unleashed

Jun 25, 2025, 4:19 AM EDT - 6 months ago

Phibro Animal Health: The Animal Is Unleashed


ProverbsP
ProverbsP Dec. 27 at 5:41 AM
$PAHC Markets appear to be rewarding companies that show durable execution rather than rapid narrative shifts. Margins must hold as the company navigates cost pressure. Credible progress tends to compress risk premiums. Execution quality becomes the defining catalyst from here.
0 · Reply
ZacksResearch
ZacksResearch Dec. 16 at 1:34 PM
$PAHC surged 93.7% in the past year — is the rally sustainable? 🚀 🐔 Strong growth in Animal Health, with MFA revenues up 81% in Q1 FY26 in nutritional specialties and vaccines 🌍 Expanding vaccine business and global footprint in approximately 90 countries 📈 Zacks Rank #1 and a 23.7% earnings surprise last quarter Discover why PAHC could keep climbing 👉 https://www.zacks.com/stock/news/2804780/is-phibro-animal-health-stock-a-smart-addition-to-your-portfolio-now?cid=sm-stocktwits-2-2804780-body-24958&ADID=SYND_STOCKTWITS_TWEET_2_2804780_BODY_24958
0 · Reply
ZacksResearch
ZacksResearch Dec. 16 at 12:07 PM
$PAHC riding a powerful Animal Health wave — but risks aren’t gone 🚀 Animal Health momentum, vaccine growth, and rising emerging market demand are driving the story, even as macro pressure and competitive risks continue to linger in the background. See the full bull vs. risk breakdown here 👉 https://www.zacks.com/stock/news/2804780/is-phibro-animal-health-stock-a-smart-addition-to-your-portfolio-now?cid=sm-stocktwits-2-2804780-teaser-24922&ADID=SYND_STOCKTWITS_TWEET_2_2804780_TEASER_24922
0 · Reply
ZacksResearch
ZacksResearch Dec. 10 at 2:41 PM
$PAHC up 59.6% so far this year — what's driving the surge? 🚀 🐾 Animal Health biz momentum & vaccine growth 🌍 Expanding in high-growth regions like Brazil & Southeast Asia 📈 Fiscal 2026 EPS expected to jump 32.1% Discover the full growth story here 👉 https://www.zacks.com/stock/news/2802112/phibro-animal-health-stock-climbs-596-ytd-whats-driving-it?cid=sm-stocktwits-2-2802112-body-24201&ADID=SYND_STOCKTWITS_TWEET_2_2802112_BODY_24201
0 · Reply
ZacksResearch
ZacksResearch Dec. 10 at 12:35 PM
$PAHC’s 59% YTD surge — is this momentum just getting started? Animal Health is firing on all cylinders, with booming vaccines and global gains even as competition heats up. That kind of strength is hard to ignore. Full breakdown here 👉 https://www.zacks.com/stock/news/2802112/phibro-animal-health-stock-climbs-596-ytd-whats-driving-it?cid=sm-stocktwits-2-2802112-teaser-24132&ADID=SYND_STOCKTWITS_TWEET_2_2802112_TEASER_24132
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Dec. 2 at 7:54 PM
$OXSQ $PACK $PAGS $PAHC $PAM Undeniable Accuracy Cycle Trading Signal plugged into AI 🔥 lists 🔥 Math don't lie 🔥
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 23 at 3:45 PM
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 17 at 10:59 AM
0 · Reply
JarvisFlow
JarvisFlow Nov. 7 at 8:06 PM
JP Morgan updates rating for Phibro Animal Health ( $PAHC ) to Overweight, target set at 45 → 50.
0 · Reply
ZacksResearch
ZacksResearch Nov. 3 at 5:44 PM
$INFU surges 75.2% in 3 months — what's fueling the rally? 🚀 🔥 Strong Patient Services & Device Solutions performance 📈 Higher treatment volume and increased third-party payer collections in Oncology and Wound Care boost revenues 🔧 Strategic restructuring with GE Healthcare underway Discover why $INFU is outperforming its peers like $PAHC, $PODD, and $LMAT 👉 https://www.zacks.com/stock/news/2783746/can-strength-in-rental-business-drive-infu-stock-before-q3-earnings?cid=sm-stocktwits-2-2783746-body-19156&ADID=SYND_STOCKTWITS_TWEET_2_2783746_BODY_19156
0 · Reply
BullishBanana
BullishBanana Oct. 26 at 6:56 PM
$QNCX $PAHC enters a licensing agreement with Lighthouse Pharmaceuticals (Quince Therapeutics has a 7.5% ownership in LHP). https://investors.pahc.com/press-releases/press-release-details/2025/Phibro-Animal-Health-Corporation-Announces-Licensing-Agreement-with-Lighthouse-Pharmaceuticals-Inc--for-Innovative-Periodontal-Health-Asset-for-Dogs/default.aspx
0 · Reply
ADXAdmiral
ADXAdmiral Oct. 5 at 4:20 PM
$PAHC Healthcare technology. Testing key support. Volume pattern shows distribution. Growth concerns persisting.
0 · Reply
ZacksResearch
ZacksResearch Sep. 25 at 2:08 PM
$PAHC surges 82.1% YTD — what's driving this incredible rally? 🚀 🐾 Strong Animal Health momentum 💊 Vaccine sales up 21% YoY 🌎 Expanding global footprint 📈 Fiscal 2025 EPS estimate up 11.7% in 30 days Discover more on this bullish setup 👉 https://www.zacks.com/stock/news/2756834/phibro-animal-health-stock-surges-821-ytd-whats-fueling-it?cid=sm-stocktwits-2-2756834-body-14105&ADID=SYND_STOCKTWITS_TWEET_2_2756834_BODY_14105
0 · Reply
ZacksResearch
ZacksResearch Sep. 25 at 12:07 PM
$PAHC up 82.1% YTD — too hot to ignore 🚀 The stock’s massive run has investors asking what’s driving the momentum and whether it’s sustainable. Full breakdown on what’s fueling the surge 👉 https://www.zacks.com/stock/news/2756834/phibro-animal-health-stock-surges-821-ytd-whats-fueling-it?cid=sm-stocktwits-2-2756834-teaser-14059&ADID=SYND_STOCKTWITS_TWEET_2_2756834_TEASER_14059
0 · Reply
RunnerSignals
RunnerSignals Sep. 11 at 12:54 PM
Bulls on Parade! $UTHR $ORCL $PAHC $CF $IRM all strutting their stuff Watch the dance, not just the flash. https://stocksrunner.com/news/2025-09-11-daily-market-pulse-advanced-technical-analysis-and-stock-trading-strategies
0 · Reply
fer69
fer69 Sep. 10 at 10:03 PM
$PAHC liquidated my whole position today … had a great run from $12 average .. 500 shares were assigned at $15 + premium and 500 at $41 .. will sell 200 shares of $PETS at a loss of over 45% by December to offset gains on same sector ..
0 · Reply
ZacksResearch
ZacksResearch Sep. 10 at 3:42 PM
$PAHC has soared 101.1% in the past year! 🚀 Is it time to double down? 🔹 Animal Health sales up 53% in fiscal Q4, boosted by $ZTS acquisition and strong international demand 🔹 Mineral Nutrition sees growth with increased demand for copper and trace minerals 🔹 Solid solvency with only $16M in short-term debt Full insights on this Zacks Rank #1 stock here 👉 https://www.zacks.com/stock/news/2749278/heres-why-you-should-add-pahc-stock-to-your-portfolio-right-now?cid=sm-stocktwits-2-2749278-body-11742&ADID=SYND_STOCKTWITS_TWEET_2_2749278_BODY_11742
0 · Reply
ZacksResearch
ZacksResearch Sep. 10 at 2:42 PM
$PAHC looks like a buy right now 🐂 Animal Health sales are climbing thanks to the Zoetis acquisition, and both Mineral Nutrition and Performance Products are rebounding. Full breakdown here 👉 https://www.zacks.com/stock/news/2749278/heres-why-you-should-add-pahc-stock-to-your-portfolio-right-now?cid=sm-stocktwits-2-2749278-teaser-11739&ADID=SYND_STOCKTWITS_TWEET_2_2749278_TEASER_11739
0 · Reply
Doozio
Doozio Aug. 29 at 12:56 AM
$PAHC moar eps gap n go 🐒🍌🧠⏰♾️
0 · Reply
ZacksResearch
ZacksResearch Aug. 28 at 1:41 PM
$PAHC shares pop 18% after Q4 earnings beat! 🚀 Phibro Animal Health’s Q4 EPS of 57 cents beat estimates by 9.62%, with net sales surging 38.6% from the year-ago quarter. Animal Health segment shined, driven by a 77% growth in medicated feed additives. 📈 Discover more on PAHC’s performance and future outlook here 👉 https://www.zacks.com/stock/news/2743968/pahc-stock-surges-on-q4-earnings-revenue-beat-gross-margin-down?cid=sm-stocktwits-2-2743968-body-9982&ADID=SYND_STOCKTWITS_TWEET_2_2743968_BODY_9982
0 · Reply
topstockalerts
topstockalerts Aug. 28 at 12:54 PM
Pre Market Top Gainers PT2 $AQB $SOGP $WHLR $GPRE $PAHC
0 · Reply
OpenOutcrier
OpenOutcrier Aug. 28 at 12:26 PM
$PAHC (+18.5% pre) $379M Quarter: Animal Health Giant Phibro Delivers Massive 39% Sales Growth with Record EBITDA Jump https://ooc.bz/l/75495
0 · Reply